Bausch + Lomb Corporation (TSX:BLCO)
28.30
-1.40 (-4.71%)
Nov 20, 2026, 12:00 PM EST
Bausch + Lomb Revenue
In the year 2025, Bausch + Lomb had annual revenue of $5.10B USD with 6.47% growth. Bausch + Lomb had revenue of $1.38B in the quarter ending September 30, 2026, with 7.34% growth.
Revenue
$5.10B
Revenue Growth
+6.47%
P/S Ratio
1.38
Revenue / Employee
$392.38K
Employees
13,000
Market Cap
10.09B CAD
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Bausch + Lomb breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.10B | 310.00M | 6.47% |
| Dec 31, 2024 | 4.79B | 645.00M | 15.56% |
| Dec 31, 2023 | 4.15B | 378.00M | 10.03% |
| Dec 31, 2022 | 3.77B | 3.00M | 0.08% |
| Dec 31, 2021 | 3.77B | 353.00M | 10.35% |
| Dec 31, 2020 | 3.41B | -366.00M | -9.69% |
| Dec 31, 2019 | 3.78B | 113.00M | 3.08% |
| Dec 31, 2018 | 3.67B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Apotex Health | 3.21B |
| Extendicare | 2.17B |
| Curaleaf Holdings | 1.92B |
| Green Thumb Industries | 1.76B |
| WELL Health Technologies | 1.56B |
| Sienna Senior Living | 1.11B |
| Vireo Growth | 956.37M |
| Knight Therapeutics | 563.45M |
Bausch + Lomb News
- 19 hours ago - Bausch + Lomb Transcript: Study result - Transcripts
- 19 hours ago - Bausch + Lomb Press release: Study result - Filings
- 19 hours ago - Bausch + Lomb Slides: Study result - Filings
- 19 hours ago - Bausch + Lomb eye-drop drug misses mid-stage study main goal - Reuters
- 20 hours ago - Bausch + Lomb says Phase 2 BL1332 study does not meet primary endpoint - TheFly
- 3 days ago - Bausch + Lomb price target raised to $27 from $24 at Barclays - TheFly
- 18 days ago - Bausch + Lomb downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 22 days ago - Bausch + Lomb price target raised to $20 from $16 at Deutsche Bank - TheFly